DYSBIOSIS AND INFLAMMATORY BOWEL DISEASE

| January 24, 2019

article image
The human body as an ecosystem in which complex interfaces consolidate signals from hosts (bacteria and human) and microbiota (bacterial and phage), and activate appropriate effector programs, in order to maintain a delicate balance. This balance is continuously under assault by behavioral and environmental factors. What we eat, what medications we take, how much exercise we get, how much stress we experience, our hygiene, our exposure to infections, and our overall immune health create disturbances in this balance.

Spotlight

Digital BioPharm ltd.

Our company is dedicated to early-stage preclinical drug discovery. Our focus is on making research in the fields of biomedicine. We are making new drugs for promising biotargets. We also develop new methods. So, our activities can be divided into two big parts.

OTHER ARTICLES

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 16, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | March 16, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | March 16, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Spotlight

Digital BioPharm ltd.

Our company is dedicated to early-stage preclinical drug discovery. Our focus is on making research in the fields of biomedicine. We are making new drugs for promising biotargets. We also develop new methods. So, our activities can be divided into two big parts.

Events